Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) has been assigned an average recommendation of “Hold” from the twenty analysts that are currently covering the company. Eleven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $15.31.

Several research firms have issued reports on MDRX. Canaccord Genuity set a $19.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a report on Thursday, October 27th. Morgan Stanley reaffirmed a “buy” rating on shares of Allscripts Healthcare Solutions in a report on Thursday, August 25th. Deutsche Bank AG upped their price objective on Allscripts Healthcare Solutions from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 5th. Argus raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a report on Thursday, August 25th. Finally, JPMorgan Chase & Co. began coverage on Allscripts Healthcare Solutions in a report on Sunday, October 30th. They set a “buy” rating and a $15.00 price objective on the stock.

TRADEMARK VIOLATION WARNING: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2016/11/30/allscripts-healthcare-solutions-inc-mdrx-receives-average-rating-of-hold-from-brokerages.html.

In other news, CEO Paul Black sold 15,000 shares of the firm’s stock in a transaction dated Thursday, September 15th. The stock was sold at an average price of $13.00, for a total value of $195,000.00. Following the completion of the transaction, the chief executive officer now owns 1,177,009 shares in the company, valued at approximately $15,301,117. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP James Hewitt sold 17,500 shares of the firm’s stock in a transaction dated Thursday, September 15th. The shares were sold at an average price of $13.00, for a total value of $227,500.00. Following the completion of the transaction, the senior vice president now owns 158,104 shares of the company’s stock, valued at approximately $2,055,352. The disclosure for this sale can be found here. 0.75% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the stock. Victory Capital Management Inc. bought a new position in shares of Allscripts Healthcare Solutions during the third quarter valued at $35,840,000. Analytic Investors LLC boosted its position in shares of Allscripts Healthcare Solutions by 4,223.2% in the third quarter. Analytic Investors LLC now owns 2,240,584 shares of the company’s stock valued at $29,509,000 after buying an additional 2,188,757 shares during the last quarter. RTW Investments LLC boosted its position in shares of Allscripts Healthcare Solutions by 1,875.6% in the third quarter. RTW Investments LLC now owns 948,286 shares of the company’s stock valued at $64,275,000 after buying an additional 900,286 shares during the last quarter. Fiduciary Management Inc. WI boosted its position in shares of Allscripts Healthcare Solutions by 26.0% in the second quarter. Fiduciary Management Inc. WI now owns 4,101,075 shares of the company’s stock valued at $52,084,000 after buying an additional 846,600 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in shares of Allscripts Healthcare Solutions by 98.3% in the third quarter. Acadian Asset Management LLC now owns 1,697,615 shares of the company’s stock valued at $22,355,000 after buying an additional 841,371 shares during the last quarter.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 10.95 on Friday. The stock’s market cap is $2.03 billion. The stock’s 50 day moving average price is $11.68 and its 200-day moving average price is $12.83. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $15.78.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its earnings results on Thursday, November 3rd. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by $0.01. The business earned $392.40 million during the quarter, compared to analyst estimates of $414.92 million. Allscripts Healthcare Solutions had a positive return on equity of 5.79% and a negative net margin of 0.14%. The firm’s revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 earnings per share. On average, analysts predict that Allscripts Healthcare Solutions will post $0.56 earnings per share for the current year.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services.

5 Day Chart for NASDAQ:MDRX

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.